Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04752462 · ClinicalTrials.gov registry record · NA

Motivational Enhancement - Acute Decompensated Heart Failure and OSA

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
75
Enrollment target

NCT04752462: Completed NA study, sponsored by The Cleveland Clinic.

NCT04752462 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04752462, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

A feasibility randomized controlled trial will be conducted with a 6-month follow up to: Examine the impact of early intensive telemedicine motivational enhancement (TIME) vs standard of care on PAP adherence (n=40/group) and continuity of care at 3 and 6 months post-discharge in patients admitted with ADHF with a new inpatient diagnosis of OSA(REI\>5). Assess the effect of early telemedicine integrated with motivational enhancement (TIME) vs standard of care on patient reported outcomes including Functional Outcomes of Sleep questionnaire (FOSQ-10), Kansas City Cardiomyopathy Questionnaire (KCCQ-12). Investigate the impact of early TIME vs standard of care on 6-month hospital readmissions.

Primary Outcome

average hourly use per night

Interventions

  • BEHAVIORAL Telemedicine Intensive Motivational Enhancement

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2021-05-13
Est. Completion 2025-01-31
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT04752462 record still lists

NCT04752462 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Telemedicine Intensive Motivational Enhancement is the first listed.

NCT04752462 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04752462 about?

NCT04752462 is a clinical study titled "Motivational Enhancement - Acute Decompensated Heart Failure and OSA". A feasibility randomized controlled trial will be conducted with a 6-month follow up to: Examine the impact of early intensive telemedicine motivational enhancement (TIME) vs standard of care on PAP adherence (n=40/group) and continuity of care at 3 and 6 months post-discharge in patients admitted w...

What is the current status of trial NCT04752462?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-05-13. Estimated completion is 2025-01-31.

What interventions are being tested in trial NCT04752462?

The interventions under investigation include: Telemedicine Intensive Motivational Enhancement (BEHAVIORAL).

Who is sponsoring clinical trial NCT04752462?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04752462's enrollment target sits among peer trials

75 1069th of 2000 higher than 919 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04752462, the US trial registry maintained by the National Library of Medicine. NCT04752462 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.